Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

Cited by (561)

Items 301–400 of 561

1. Depression and pain: the need for a new screening tool
   Karen Amanda Cocksedge, Rohit Shankar, Chantal Simon · 2016 · Progress in Neurology and Psychiatry
2. Single Treatment With Capsaicin 8% Patch May Reduce Pain and Sleep Interference up to 12 Weeks in Patients With Painful Diabetic Peripheral Neuropathy
   Daniel A. Ostrovsky · 2017 · EXPLORE
3. Therapeutic effects of diclofenac, pregabalin, and duloxetine on disuse-induced chronic musculoskeletal pain in rats
   Yusuke Ohmichi, Mika Ohmichi, Nobuhito Murai, Masaya Yasui, Nobuaki Takeshita, Hidehiro Oshibuchi, Munekazu Naito, Takashi Nakano, Jun Sato · 2018 · Scientific Reports
4. Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain)
   Daniel H. Strauss, Divya R. Santhanam, Samuel A. McLean, Francesca L. Beaudoin · 2019 · BMJ Open
5. Efficacy of Duloxetine on the Duration of Spinal Anesthesia and Acute Post-Operative Pain after Hip Surgery Prospective Randomized Controlled Study
   MOHAMED S. EL-BEHAIRY, M.Sc.; SALAMA I. EL-HAWARY, M.D., Mai Elsheikh · 2019 · The Medical Journal of Cairo University/The Medical Journal of Cairo University
6. Postoperative Analgesia in the Chronic Pain Patient
   Natasa Grancaric, Woo-Jin Lee, Madeline Scanlon · 2020 · Otolaryngologic Clinics of North America
7. Pain and Pain Management
   Abigail E. Franklin, Melanie R Lovell · 2019 · Springer eBooks
8. Long‐term efficacy of 10 kHz spinal cord stimulation in managing painful diabetic neuropathy: A post‐study survey
   Erika Petersen, Shawn M. Sills, Thomas G. Stauss, Rose Province‐Azalde, Michael J. Jaasma, Deborah R. Edgar, Judith L. White, James A. Scowcroft, Cong Yu, Jijun J. Xu et al. · 2025 · Pain Practice
9. Phytochemical Modulators of Nociception: A Review of Cannabis Terpenes in Chronic Pain Syndromes
   Aniello Alfieri, Sveva Di Franco, Vincenzo Maffei, Pasquale Sansone, Maria Caterina Pace, Maria Beatrice Passavanti, Marco Fiore · 2025 · Pharmaceuticals
10. Unlocking Novel Therapeutic Potential of Angiotensin II Receptor Blockers
    Filippos Panteleimon Chatzipieris, Kyriaki Mavromoustakou, John Matsoukas, Thomas Mavromoustakos · 2025 · International Journal of Molecular Sciences
11. Cannabis-based medicines for chronic neuropathic pain in adults
    Gülay Ateş, Patrick Welsch, Petra Klose, Tudor Phillips, Britta Lambers, Winfried Häuser, L Radbruch · 2026 · Cochrane Database of Systematic Reviews
12. Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials
    Hongzhi Zhong, Jianhang Li, Yuxiang Chen, Yicong Huang, Zhishen Wen, Jun Zhao · 2023 · International Journal of Clinical Pharmacy
13. Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.
    Rejina Kamrul, Debbie Bunka, Alex Crawley, Brenda G. Schuster, Marlys H. LeBras · 2019 · Europe PMC (PubMed Central)
14. Pathogenic Role of iNOs+ M1 Effector Macrophages in Fibromyalgia
    Vishwas Tripathi, Amaresh Mishra, Yamini Pathak, Aklank Jain, Hridayesh Prakash · 2020 · IntechOpen eBooks
15. The Role of Psychiatric, Analgesic, and Antiepileptic Medications in Chronic Pruritus
    Parth Sudhendu Patel, Keshav R Patel, Karan Pandher, Ruqiya Shama Tareen · 2021 · Cureus
16. Depression and pain: An appraisal of cost effectiveness and cost utility of antidepressants
    Yi‐Ju Pan, Chun–Hao Pan, Hung‐Yu Chan, Kuei‐Hong Kuo · 2015 · Journal of Psychiatric Research
17. Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain: Understanding and Management
    Hans Törnblom, Douglas A. Drossman · 2016 · Handbook of experimental pharmacology
18. Duloxetine as an Analgesic in Patients Who Do Not Have Central Sensitivity Undergoing Single-Setting, Bilateral Total Knee Arthroplasty: A Prospective, Double-Blinded, Randomized, Placebo-Controlled Trial
    Amyn M Rajani, Anmol R. S. Mittal, Vishal U Kulkarni, Megha K. Desai, Rishab R. Dubey, Khushi A Rajani, Kashish A Rajani · 2024 · The Journal of Arthroplasty
19. Duloxetine enhances the sensitivity of non-small cell lung cancer cells to EGFR inhibitors by REDD1-induced mTORC1/S6K1 suppression
    Se‐Kyeong Jang · 2024 · American Journal of Cancer Research
20. Somatoforme Störungen – somatoforme Belastungsstörung und verwandte Störungen
    Hans‐Peter Kapfhammer · 2017 · Springer eBooks
21. Nerve growth factor for neuropathic pain
    Yang Zhang, Siyin Gong, Li He, Muke Zhou, Jian Guo, Ahmet Höke, Cairong Zhu · 2017 · Cochrane Database of Systematic Reviews
22. Alpha-lipoic acid for diabetic peripheral neuropathy
    Cristian Băicuş, Adrian Purcărea, Erik B von Elm, Caterina Delcea, Florentina Furtunescu · 2018 · Cochrane Database of Systematic Reviews
23. Pain, negative affective states and opioid-based analgesics: Safer pain therapies to dampen addiction
    Nicolas Massaly, Tamara Markovic, Meaghan C. Creed, Ream Al‐Hasani, Catherine M. Cahill, José A. Morón · 2021 · International review of neurobiology
24. Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update
    Cornelius James Fernandez · 2022 · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
25. Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort
    Pankti Mehta, Amartya Basu, Sakir Ahmed · 2022 · Rheumatology International
26. Mechanism-Based Pharmacological Treatment for Chronic Non-cancer Pain in Adolescents: Current Approaches and Future Directions
    Alice Bruneau, Sabrina Carrié, Lorenzo Moscaritolo, Pablo Mauricio Ingelmo · 2022 · Pediatric Drugs
27. Tolerability and efficacy of duloxetine for the prevention of persistent musculoskeletal pain after trauma and injury: a pilot three-group randomized controlled trial
    Francesca L. Beaudoin, Rachel Gaither, Weston C de Lomba, Samuel A. McLean · 2022 · Pain
28. Duloxetine for Postoperative Pain Control Following Knee or Hip Replacement: A Systematic Review and Meta-Analysis
    Ian A. Jones, Arad Talehakimi, Linda Suk-Ling Murphy, Jennifer C. Wang, Amit S. Piple, Alexander B. Christ, Nathanael D. Heckmann · 2023 · Arthroplasty Today
29. Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial—BLOSSOM
    Martin Rakuša, Iris Marolt, Zorica Stević, Sandra Vučković Rebrina, Tatjana Milenković, Adam Stępień · 2023 · Pharmaceuticals
30. The efficacy and safety of duloxetine for the treatment of patients after TKA or THA: A systematic review and meta-analysis
    Yongqiang Zhou, Xiao Chen, Ge Chen, Yuan Cao · 2023 · Medicine
31. Análise da Revisão Cochrane: Pregabalina no Tratamento da Dor Crónica Moderada a Grave em Adultos com Fibromialgia. Cochrane Database Syst Rev. 2016;9:CD011790 e 2016;4:CD009002
    Guilherme Ferreira‐Dos‐Santos, David Cordeiro Sousa, João N. Costa, António Vaz Carneiro · 2018 · Acta Médica Portuguesa
32. Pharmacological therapies for fibromyalgia in adults - an overview of Cochrane Reviews
    Winfried Häuser, Patrick Welsch, Petra Klose, Sheena Derry, Sebastian Straube, Philip J Wiffen, Andrew Moore · 2018 · Cochrane Database of Systematic Reviews
33. Treat the Patient, Not the Label: A Pain Neuroscience Update
    Adriaan Louw, Stephen G. Schmidt, Kory J. Zimney, Emilio J. Puentedura · 2019 · Journal of Womenʼs Health Physical Therapy
34. Intravenous Ketamine for Cancer Pain Management, Including Flares During the COVID-19 Pandemic: A Retrospective Study
    Daniel Chun‐suk Oh, Paul Ryan Haffey, Ankur A. Patel, Amitabh Gulati · 2021 · Pain Medicine
35. Optimization and in vivo evaluation of duloxetine hydrochloride buccoadhesive lyophilized tablets
    Amr Mostafa El Sharawy, Marwa Hassan Shukr, Ahmed Hassen Elshafeey · 2019 · Journal of Drug Delivery Science and Technology
36. Painful diabetic polyneuropathy: evidence-based diagnosis and treatment
    V.N. Khramilin, О.С. Давыдов · 2021 · Russian Journal of Pain
37. Multimodal Approaches in the Treatment of Chronic Peripheral Neuropathy—Evidence from Germany
    Tobias Romeyke, Harald Stummer · 2024 · International Journal of Environmental Research and Public Health
38. Comparative Study of the Effects of Duloxetine and Venlafaxine on Acute Symptomatic Taxane-induced Neuropathy in Breast Cancer Patients: a randomized clinical trial
    Hanieh Radkhah, Mohsen Esfandbod, Mohammad Amin Khadembashiri, M. R. Eslami, Farnaz Etesam, Farhad Shahi, Parnian Shobeiri, Melika Rafiemehr · 2024 · Journal of Community Hospital Internal Medicine Perspectives
39. Pharmacologic and Nonpharmacologic Management of Neuropathic Pain
    Andrew Feldman, Joshua Weaver · 2024 · Seminars in Neurology
40. Evaluating the Effect of Duloxetine Premedication on Postoperative Analgesic Requirement in Patients Undergoing Laparoscopic Cholecystectomies
    Shivika Nath, Ambhrin Saha, Aarti Srivastava · 2022 · Clinical Journal of Pain
41. A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain
    Boris Tabakoff, Wen-Hua Ren, Lauren A. Vanderlinden, Lawrence D. Snell, Christopher J. Matheson, Zejun Wang, Rock Levinson, C. Thetford Smothers, John J. Woodward, Yumiko Honse et al. · 2016 · European Journal of Pharmacology
42. Individualized Treatment Strategy for Depressive Disorder
    Jun Chen, Shaohua Hu · 2019 · Advances in experimental medicine and biology
43. Prescribing in renal supportive care
    Kelly Li, Mark Ashley Brown · 2020 · Australian Prescriber
44. A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder
    György Szekeres, Sándor Rózsa, Péter Döme, Gabor Barsony, Xénia Gonda · 2021 · Frontiers in Psychiatry
45. Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy–Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment
    Célia Matta, Laurence Meyer, Ayikoe Guy Mensah‐Nyagan, Omar Taleb · 2020 · Neurotoxicity Research
46. Pharmacological Treatment of Fibromyalgia
    Emma Kathryn Guymer, Geoffrey Owen Littlejohn · 2021 · Springer eBooks
47. Evidence on Acupuncture and Pain: Reporting on a Work in Progress
    Karen Pilkington · 2015 · Journal of Acupuncture and Meridian Studies
48. Duloxetine for Subacute Pain Management after Total Knee Arthroplasty
    Michael B. Jacobs, Steven Paul Cohen · 2016 · Anesthesiology
49. Widespread Pain Phenotypes Impact Treatment Efficacy Results in Randomized Clinical Trials for Interstitial Cystitis/ Bladder Pain Syndrome: A MAPP Network Study
    John T. Farrar, Kenneth Locke, James Quentin Clemens, James William Griffith, Steven E. Harte, Ziya Kırkalı, Karl J. Kreder, John N. Krieger, H. Henry Lai, Robert Moldwin et al. · 2023 · Research Square
50. Early optimized pharmacological treatment in patients with depression and chronic pain
    Oloruntoba J. Oluboka, Martin A. Katzman, Jeffrey Habert, Atul Khullar, Margaret A. Oakander, Diane McIntosh, Roger S. McIntyre, Cláudio N. Soares, Raymond Wing Moon Lam, Larry J. Klassen et al. · 2022 · CNS Spectrums
51. Diabetische Neuropathie und diabetischer Fuß (Update 2023)
    Gerd Köhler, Marlies Eichner, Heidemarie Abrahamian, Markus Köfler, Wolfgang Sturm, Anja Menzel · 2023 · Wiener klinische Wochenschrift
52. ZY5301 Tablet vs Placebo for Treatment of Chronic Pelvic Pain After Pelvic Inflammatory Disease
    Xiuxiang Teng, Hongmei Li, Defeng Yang, Zheng Gao, Li Cui, Hong Chen, Qingxia Song, Lianwei Xu, Huaifang Li, Qin Zhang et al. · 2024 · JAMA Network Open
53. Trends on Nanomedicines as Novel therapeutics Approach in Targeting Nociceptors for Relieving Pain
    Trilochan Satapathy, Deepak Kumar Sahu, Himanshu Sahu, Ravindra Kumar Pandey, Shiv Shankar Shukla, Bina Gidwani · 2024 · Current Drug Targets
54. A Systematic Review of Dietary Lifestyle Interventions for Neuropathic Pain
    Michael Klowak, Rachel Lau, Mariyam N. Mohammed, Afia Birago, Bethel Samson, Layla Ahmed, Camille Renee, Milca Meconnen, Mehmet Sam, Andrea K. Boggild · 2024 · Journal of Clinical Medicine
55. Somatic symptom disorder, a new DSM-5 diagnosis of an old clinical challenge
    Tea Rosic, Sameer Kalra, Zainab Samaan · 2016 · BMJ Case Reports
56. Okada Purifying Therapy in combination with duloxetine vs. duloxetine alone in patients with TMD and fibromyalgia: a randomized clinical study
    Gianluca Bruti, Manuela Ramos Atencio, Anna D’Urso, Paola Di Giacomo, Carlo Di Paolo · 2020 · Journal of Complementary and Integrative Medicine
57. Serotonin-Norepinephrine Reuptake Inhibitors
    Robert M. Chow, Mohammed Issa · 2017 · Springer eBooks
58. The triple monoamine re-uptake inhibitor DOV 216,303 promotes functional recovery after spinal cord contusion injury in mice
    Tak‐Ho Chu, Karen Cummins, Peter K. Stys · 2018 · Neuroscience Letters
59. Persistent and Widespread Pain Among Blacks Six Weeks after MVC: Emergency Department-based Cohort Study
    Francesca L. Beaudoin, Wanting Zhai, Roland Clayton Merchant, Melissa A. Clark, Michael Christopher Kurz, Phyllis L. Hendry, Robert A. Swor, David A. Peak, Claire Pearson, Robert M. Domeier et al. · 2021 · Western Journal of Emergency Medicine
60. Neuropatía Diabética: Una revisión narrativa de fisiopatología, diagnóstico y tratamiento.
    Gilberto A. Jiménez-Castillo, Luis E. Martínez‐Bravo, Antonio Anaya‐Escamilla · 2023 · ACTA MEDICA PERUANA
61. Pharmacologic treatment of fibromyalgia: an update
    Yang Li, Yunshen Li, Shiya Wu, Meijuan Long, Xinyi Chen, Yidan Wang, Jianan Zhao, Bingheng He, Cen Chang, Juan Jiao · 2025 · Frontiers in Pharmacology
62. Role of Palliative Care in the Supportive Management of AL Amyloidosis—A Review
    Muhammad Hamza Habib, Yun Kyoung Tiger, Danai Dima, Mathias Schlögl, Alexandra McDonald, Sandra Ann Mazzoni, Jack Khouri, Louis S. Williams, Faiz Anwer, Shahzad Raza · 2024 · Journal of Clinical Medicine
63. Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study
    Surya Sridharan, Simon Erridge, Carl Holvey, Ross Coomber, Wendy Holden, James Rucker, Michael W. Platt, Mikael Hans Sodergren · 2024 · Journal of Pain & Palliative Care Pharmacotherapy
64. Antidepressant drugs for neuropathic pain - an overview of Cochrane reviews
    Andrew Moore, Eija Anneli Kalso, Philip J Wiffen, Sheena Derry, Thomas Rudolf Tölle, Nanna Brix Finnerup, Nadine Attal, Michael Peter Lunn · 2017 · Cochrane Database of Systematic Reviews
65. Duloxetine suppresses BMP-4-induced release of osteoprotegerin via inhibition of the SMAD signaling pathway in osteoblasts
    Junko Tachi, Takashi Onuma, Shinobu Yamaguchi, Woo Young Kim, Tomoyuki Hioki, Rie Matsushima‐Nishiwaki, Kumiko Tanabe, Haruhiko Tokuda, Osamu Kozawa, Hiroki Iida · 2021 · Biochemistry and Cell Biology
66. Off‐label pharmacological treatment for neuropathic pain: A Delphi study by the Spanish Pain Society Neuropathic Pain Task Force
    Ancor Serrano Afonso, Rafael Gálvez, Elena Paremés, Ana M. Navarro, Dolores Ochoa, Concepción Pérez · 2022 · Pain Practice
67. Efficacy of Combination Therapy with Pregabalin in Neuropathic Pain: A Preclinical Study in the Rat L5 Spinal Nerve Ligation Model
    Kazutaka Nozawa, Yusuke Karasawa, Yuka Shidahara, Takahiro Ushida · 2022 · Journal of Pain Research
68. The anterior cingulate cortex contributes to the analgesic rather than the anxiolytic effects of duloxetine in chronic pain-induced anxiety
    Chenglin Li, Kaiji Ni, Meiru Qi, Jie Li, Kexin Yang, Yanli Luo · 2022 · Frontiers in Neuroscience
69. Depression, Angststörungen, bipolare Störung, Schizophrenie, Aufmerksamkeitsdefizithyperaktivitätssyndrom
    Johanna Seifert, Stefan Bleich, Roland Seifert · 2022 · Springer eBooks
70. Pain Management in Dermatology
    Mathilde Hayoun, L. Misery · 2023 · Dermatology
71. Safety and Efficacy of Compression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy in Lower Extremities of Breast Cancer Patients: A Pilot Study
    Mai Okazaki, Hiroko Bando, Azusa Terasaki, Aya Ueda, Akiko Iguchi‐Manaka, Bryan James Mathis, Hisato Hara · 2024 · Cureus
72. Assessing the Risk for Falls in Older Adults After Initiating Gabapentin Versus Duloxetine
    Alexander Chaitoff, Rishi J. Desai, Niteesh K. Choudhry, Katharina Tabea Jungo, Nancy Haff, Julie C. Lauffenburger · 2025 · Annals of Internal Medicine
73. Severe medication-induced peripheral neuropathy treated with topical doxepin cream in a paediatric patient with leukaemia
    Zephyr D. Dworsky, Rebecca Bennett, Jenny M Kim, Dennis John Kuo · 2017 · BMJ Case Reports
74. Medically unexplained syndromes: irritable bowel syndrome, fibromyalgia and chronic fatigue
    Jason S. Luty · 2018 · BJPsych Advances
75. Basic guide to chronic pain assessment: from neurophysiology to bedside
    Gabriele Finco, Maurizio Evangelista, Salvatore Sardo · 2020 · Minerva Anestesiologica
76. A secondary analysis of PAIN‐CONTRoLS: Pain's impact on sleep, fatigue, and activities of daily living
    Salman F Bhai, Alexandra R. Brown, Byron J. Gajewski, Kim S. Kimminau, Lemuel Russell Waitman, Mamatha Pasnoor, Richard J. Barohn, the PAIN‐CONTRoLS Study Team · 2022 · Muscle & Nerve
77. A pilot study on the efficacy of an Antiaris toxicaria subsp. africana (Engl.) C.C. Berg based Ghanaian herbal product in the management of peripheral neuropathy
    Ronald Yeboah, Kwesi Prah Thomford, Rudolph Mensah, Alfred Ampomah Appiah, Ama Kyeraa Thomford, Augustine Ocloo · 2019 · Journal of Pharmacy & Pharmacognosy Research
78. Chronic pain, a narrative review for the internist in 2024
    Silvia Sovaila, Adrian Purcărea, Andrea Elena Neculau · 2023 · Romanian Journal of Internal Medicine
79. Sleep Disturbances in General Medical Disorders
    Sudhansu Chokroverty · 2017 · Springer eBooks
80. Treatment of Diabetic Peripheral Neuropathy
    Nada M. Farhat, Krista L. Yezback · 2016 · The Journal for Nurse Practitioners
81. HIV and peripheral neuropathy
    Nu Cindy Chai, Justin C. McArthur · 2016
82. Hydromorphone for neuropathic pain in adults
    Dominic J. Aldington, Peter Cole, Roger Knaggs, Cathy Stannard, Sheena Derry, Philip J Wiffen, Andrew Moore · 2015 · Cochrane Database of Systematic Reviews
83. Zonisamide for neuropathic pain in adults
    Andrew Moore, Philip J Wiffen, Sheena Derry, Michael Peter Lunn · 2014 · Cochrane Database of Systematic Reviews
84. Amitriptyline and duloxetine attenuate activities of superficial dorsal horn neurons in a rat reserpine-induced fibromyalgia model
    Daisuke Uta, Katsuyuki Tsuboshima, Kazue Mizumura, Hisao Nishijo, Toru Taguchi · 2024 · Journal of Pharmacological Sciences
85. Polyneuropathie im Alter
    Wolfgang N. Löscher, Bernhard Iglseder · 2017 · Zeitschrift für Gerontologie und Geriatrie
86. The Medication Guidelines for Neuropathic Pain Including Fibromyalgia is justified from a Scientific Viewpoint, However, it does Not Necessarily Agree with Clinical Priority
    Katsuhiro Toda · 2018
87. Should Pregabalin Be Used in the Management of Chronic Neuropathic Pain in Adults? A Cochrane Review Summary With Commentary
    Carlotte Kiekens · 2019 · PM&R
88. Schmerztherapie im Alter: Besonderheiten und Empfehlungen
    Georg Pinter, Waltraud Stromer, Josef Donnerer, Svetlana Geyrhofer, Burkhard F. Leeb, Nenad Mitrovic, Katharina Pils, Ruldolf Likar · 2020 · Zeitschrift für Gerontologie und Geriatrie
89. Local Administration of ElectroMagnetic Field as Add-On Therapy in the Treatment of Chronic Facial Pain: A Pilot Study
    Marco Storari, Nicoletta Zerman, Enrico Spinas · 2022 · International Journal of Environmental Research and Public Health
90. Chronic Facial Pain in Fibromyalgia: May ElectroMagnetic Field Represent a Promising New Therapy? A Pilot Randomized-Controlled Study
    Marco Storari, Nicoletta Zerman, Benedetta Salis, Enrico Spinas · 2022 · International Journal of Environmental Research and Public Health
91. Does postoperative low-dose duloxetine provide analgesic effect and lower morphine consumption after primary total knee arthroplasty? A prospective, double-blind, randomized controlled trial
    Piya Pinsornsak, Jakkarin Phunphakchit, Prem Pinsornsak, Krit Boontanapibul · 2024 · Archives of Orthopaedic and Trauma Surgery
92. Peripheral Neuropathic Pain
    Victor C. Wang, Miroslav Bačkonja · 2024 · CONTINUUM Lifelong Learning in Neurology
93. Pharmacology of pain management in general practice
    Christopher Evans, Alison Hoggarth, Colm Lanigan · 2016 · InnovAiT Education and inspiration for general practice
94. Updates in the Approach to Chronic Pelvic Pain: What the Treating Gynecologist Should Know
    Erin T. Carey, Kristin J. Moore · 2019 · Clinical Obstetrics & Gynecology
95. Unravelling Impaired Hypoalgesia at Rest and in Response to Exercise in Patients with Chronic Whiplash-Associated Disorders: Effects of a Single Administration of Selective Serotonin Reuptake Inhibitor versus Selective Norepinephrine Reuptake Inhibitor
    Margot De Kooning, Iris Coppieters, Eva Huysmans, Jo Nijs, Mira Meeus, Lennard P. Voogt, Erwin Paul Hendriks, Kelly Ickmans · 2023 · Journal of Clinical Medicine
96. Serotonin Reuptake Inhibitors and Their Role in Chronic Pain Management
    Adela Hilda Onuțu, Dan Sebastian Dîrzu, Cristina Petrișor · 2019 · IntechOpen eBooks
97. Neuropathic Orofacial Pain
    Olga Anna Korczeniewska, Katherine France, Junad Khan, Martin S. Greenberg, Rafael Benoliel, Eli Eliav · 2021 · Wiley eBooks
98. Why It Is Important to Consider the Effects of Analgesics on Sleep: A Critical Review
    Stella Iacovides, Peter R. Kamerman, Fiona C. Baker, Duncan Mitchell · 2021 · Comprehensive physiology
99. Central sensitization in chronic lumbar spine pain – pathophysiology and diagnostics
    Barabara Kosińska, Paweł Turczyn, Krzysztof Wesołowski, Beata Tarnacka, Małgorzata Malec‐Milewska · 2020 · Ból
100. Therapie der Polyneuropathie – autonome Symptome und Schmerzen
     Juliane Sachau, Sophie‐Charlotte Fabig, Stefanie Rehm, Ralf Baron · 2020 · Der Internist